PH21868A - Novel cyclosporins - Google Patents

Novel cyclosporins

Info

Publication number
PH21868A
PH21868A PH32013A PH32013A PH21868A PH 21868 A PH21868 A PH 21868A PH 32013 A PH32013 A PH 32013A PH 32013 A PH32013 A PH 32013A PH 21868 A PH21868 A PH 21868A
Authority
PH
Philippines
Prior art keywords
novel cyclosporins
cyclosporins
novel
Prior art date
Application number
PH32013A
Other languages
English (en)
Inventor
Roland Wenger
Rene P Traber
Hans Kobel
Hans Hofmann
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB848407618A external-priority patent/GB8407618D0/en
Priority claimed from GB848411922A external-priority patent/GB8411922D0/en
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of PH21868A publication Critical patent/PH21868A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C07K7/645—Cyclosporins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/19—Antibiotic
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/27—Cyclic peptide or cyclic protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Transplantation (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PH32013A 1984-03-23 1985-03-20 Novel cyclosporins PH21868A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB848407618A GB8407618D0 (en) 1984-03-23 1984-03-23 Organic compounds
GB848411922A GB8411922D0 (en) 1984-05-10 1984-05-10 Organic compounds

Publications (1)

Publication Number Publication Date
PH21868A true PH21868A (en) 1988-03-25

Family

ID=26287502

Family Applications (2)

Application Number Title Priority Date Filing Date
PH32013A PH21868A (en) 1984-03-23 1985-03-20 Novel cyclosporins
PH32014A PH23357A (en) 1984-03-23 1985-03-20 Cyclosporin compound,pharmaceutical composition containing said compound and method of use thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
PH32014A PH23357A (en) 1984-03-23 1985-03-20 Cyclosporin compound,pharmaceutical composition containing said compound and method of use thereof

Country Status (24)

Country Link
US (1) US4639434A (enExample)
JP (1) JPH08838B2 (enExample)
AT (1) AT388737B (enExample)
BE (1) BE901980A (enExample)
CA (1) CA1247546A (enExample)
CH (1) CH667274A5 (enExample)
CS (1) CS249542B2 (enExample)
DE (1) DE3509809A1 (enExample)
DK (1) DK128285A (enExample)
ES (1) ES8702926A1 (enExample)
FI (1) FI851120L (enExample)
FR (1) FR2561651B1 (enExample)
GB (1) GB2155936B (enExample)
GR (1) GR850716B (enExample)
HU (1) HU200786B (enExample)
IL (1) IL74681A (enExample)
IT (1) IT1199962B (enExample)
LU (1) LU85819A1 (enExample)
NL (1) NL8500828A (enExample)
NO (1) NO851160L (enExample)
NZ (1) NZ211526A (enExample)
PH (2) PH21868A (enExample)
PT (1) PT80149B (enExample)
SE (1) SE461334B (enExample)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0290762B1 (en) 1984-10-04 1993-05-12 Sandoz Ag Cyclosporins
US4798823A (en) * 1987-06-03 1989-01-17 Merck & Co., Inc. New cyclosporin analogs with modified "C-9 amino acids"
EP0296122B1 (en) * 1987-06-17 1993-09-29 Sandoz Ag Cyclosporins and their use as pharmaceuticals
EP0373260B1 (en) * 1987-06-22 1994-03-09 Merck & Co. Inc. Cyclosporin derivatives with modified "8-amino acid"
US5227467A (en) * 1987-08-03 1993-07-13 Merck & Co., Inc. Immunosuppressive fluorinated cyclosporin analogs
US4839342A (en) * 1987-09-03 1989-06-13 University Of Georgia Research Foundation, Inc. Method of increasing tear production by topical administration of cyclosporin
EP0391909B1 (en) * 1987-09-03 1994-08-17 The University Of Georgia Research Foundation, Inc. Ocular cyclosporin composition
US5089390A (en) * 1987-09-04 1992-02-18 Syntex (U.S.A.) Inc. 2-methyl-4-hexene- and 2-methyl-4-heptene-1,2-diol derivatives
US5236899A (en) * 1987-11-16 1993-08-17 Merck & Co., Inc. 6-position cyclosporin a analogs as modifiers of cytotoxic drug resistance
US4914188A (en) * 1987-11-16 1990-04-03 Merck & Co., Inc. Novel 6-position cyclosporin analogs as non-immunosuppressive antagonists of cyclosporin binding to cyclophilin
CH679119A5 (enExample) * 1988-05-13 1991-12-31 Sandoz Ag
US5540931A (en) * 1989-03-03 1996-07-30 Charles W. Hewitt Methods for inducing site-specific immunosuppression and compositions of site specific immunosuppressants
US4996193A (en) * 1989-03-03 1991-02-26 The Regents Of The University Of California Combined topical and systemic method of administration of cyclosporine
GB8916901D0 (en) 1989-07-24 1989-09-06 Sandoz Ltd Improvements in or relating to organic compounds
US5122511A (en) * 1990-02-27 1992-06-16 Merck & Co., Inc. Immunosuppressive cyclosporin analogs with modified amino acids at position-8
US5202310A (en) * 1990-06-06 1993-04-13 Levy Gary A Cyclosporine metabolites
ES2095926T5 (es) * 1990-11-02 2001-02-16 Novartis Ag Cyclosporins.
ES2091301T3 (es) * 1990-11-20 1996-11-01 Behringwerke Ag Inmunoensayo de ciclosporina.
US5747330A (en) * 1996-06-05 1998-05-05 Poli Industria Chimica Antibiotic producing microbe
RU2170741C2 (ru) * 1996-08-16 2001-07-20 Новартис Аг Способ получения циклоспорина
US20030220234A1 (en) * 1998-11-02 2003-11-27 Selvaraj Naicker Deuterated cyclosporine analogs and their use as immunodulating agents
JP4261049B2 (ja) 1997-10-08 2009-04-30 アイソテクニカ インコーポレイテッド 重水素化シクロスポリンアナログおよび免疫調節剤としてのそれらの使用
US5990274A (en) 1997-11-25 1999-11-23 Dade Behring Inc. Cyclosporine derivatives and uses thereof
US7449544B2 (en) * 1999-11-30 2008-11-11 Cyclacel Limited p21 peptides
WO2003032949A1 (en) * 2001-10-19 2003-04-24 Isotechnika Inc. Novel cyclosporin analog microemulsion preconcentrates
HRP20070058B1 (hr) * 2001-10-19 2014-05-23 Isotechnika Inc. Sinteza ciklosporinskih analoga
WO2004082629A2 (en) * 2003-03-17 2004-09-30 Albany Molecular Research, Inc. Novel cyclosporins
EP1809656A4 (en) * 2004-09-29 2009-03-25 Amr Technology Inc CYCLOSPORINAL KINANALOGA AND ITS PHARMACEUTICAL APPLICATIONS
JP2008514702A (ja) * 2004-09-29 2008-05-08 エーエムアール テクノロジー インコーポレイテッド 新規シクロスポリン類似体およびそれらの薬学的使用
WO2006041631A2 (en) * 2004-10-06 2006-04-20 Amr Technology, Inc. Novel cyclosporin alkynes and their utility as pharmaceutical agents
US7696165B2 (en) * 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders
US7696166B2 (en) * 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders
WO2008069917A2 (en) 2006-11-20 2008-06-12 Scynexis, Inc. Novel cyclic peptides
KR20190002731A (ko) 2010-12-15 2019-01-08 콘트라빌 파마슈티컬스, 인코퍼레이티드 아미노산 1 및 3에서 변형된 사이클로스포린 유사체 분자
HUE044591T2 (hu) 2011-03-11 2019-11-28 Beth Israel Deaconess Medical Ct Inc Anti-CD40 antitestek és alkalmazásuk
CN104877013B (zh) * 2015-06-03 2018-04-20 兰州大学 环孢菌素t及其制备方法和应用
KR102779818B1 (ko) 2015-09-04 2025-03-11 프리마토프 테라퓨틱스 인크. 인간화 항-cd40 항체 및 그의 용도

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57140753A (en) * 1981-01-09 1982-08-31 Sandoz Ag Novel cyclosporine
DE3260468D1 (en) * 1981-01-09 1984-09-06 Sandoz Ag Novel cyclosporins

Also Published As

Publication number Publication date
FI851120A0 (fi) 1985-03-20
ATA86385A (de) 1989-01-15
CA1247546A (en) 1988-12-28
DK128285A (da) 1985-09-24
PH23357A (en) 1989-07-14
BE901980A (fr) 1985-09-23
FR2561651B1 (fr) 1990-03-09
US4639434A (en) 1987-01-27
JPS60215700A (ja) 1985-10-29
GB2155936A (en) 1985-10-02
NL8500828A (nl) 1985-10-16
ES8702926A1 (es) 1987-01-16
CS249542B2 (en) 1987-03-12
AT388737B (de) 1989-08-25
IL74681A (en) 1989-09-10
SE8501392D0 (sv) 1985-03-21
LU85819A1 (fr) 1985-12-12
PT80149B (en) 1987-03-23
ES541465A0 (es) 1987-01-16
JPH08838B2 (ja) 1996-01-10
SE8501392L (sv) 1985-09-24
GB8507270D0 (en) 1985-04-24
IT8547852A0 (it) 1985-03-22
FI851120A7 (fi) 1985-09-24
HUT38370A (en) 1986-05-28
GR850716B (enExample) 1985-07-19
SE461334B (sv) 1990-02-05
NO851160L (no) 1985-09-24
GB2155936B (en) 1987-09-16
CH667274A5 (de) 1988-09-30
HU200786B (en) 1990-08-28
PT80149A (en) 1985-04-01
DE3509809A1 (de) 1986-01-09
FR2561651A1 (fr) 1985-09-27
NZ211526A (en) 1988-08-30
FI851120L (fi) 1985-09-24
IT1199962B (it) 1989-01-05
IL74681A0 (en) 1985-06-30
IT8547852A1 (it) 1986-09-22
DK128285D0 (da) 1985-03-21

Similar Documents

Publication Publication Date Title
GB2155936B (en) Cyclosporins
GB8516281D0 (en) Peptides
EP0173557A3 (en) Peptides
ZA855092B (en) Novel isoindolinyl-alkyl-piperazines
SG32390G (en) Novel 8a-acylaminoergolines
EP0191269A3 (en) Novel homopropargylamines
DE3560261D1 (en) Peptides
ZA852440B (en) Novel substituted-aminohydroxypropoxy-thiadiazoles
ZA852195B (en) Novel cyclosporins
ZA858971B (en) Novel homopropargylamines
ZA857138B (en) Sanitant arrangement
CS160084A1 (en) Zpusob pripravy modifikovanych polyesteru
ZA861805B (en) Novel cyclosporins
GB8402317D0 (en) Peptides
IE840662L (en) Peptides
IE841305L (en) Peptides
IE841780L (en) Heptapeptide
CS596084A1 (en) Priznakovy pristrojovy preprocesor systemu prumysloveho rozpoznavani v regalnem case
CS877884A1 (en) Zarizeni k mereni zmeny velikosti snimane fyzikalni veliciny v case
IE850731L (en) Cyclosporins
CS113884A1 (en) Zpusob fermentacni pripravy l lysinu
BG38141A1 (en) Videoconverter
AU91199S (en) Tea-towel
CS64784A1 (en) Zpusob krckoveho dlouzeni syntetickych vlaken
BG38438A1 (en) Hydrotransformator